Home Infusion Therapy Market Analysis, Top Companies, New Technology, Demand and Opportunity Analysis

Infusion therapy is referred to a medical procedure by which a drug is administered intravenously or can also be provided through other non-oral routes such as intramuscular injections and epidural routes into the membranes that surround spinal cord. Home Infusion therapy engages administration of intravenous pills into the consumer’s body, with the help of needle or catheter, at their homes based on the doctor’s prescription. Home infusion therapy is mostly done when oral medications are not effective to cure the disease. Home infusion therapy offers advantage over others therapy in its class, as it reduces time spent in hospitals, nursing homes and clinics, and is provided by trained professionals.

Home Infusion therapy is an effective and safe alternative for patient care because it provides friendly environment, which helps patients in early recovery. Infections which are not cured by oral medication, such as gastrointestinal diseases, cancer, cancer related pain and dehydration, are cured by home infusion therapy. Home infusion therapy is also used for curing health failure, diabetes, dehydration, cystic fibrosis, acute infections and nutritional support. Some of the infusion therapy devices, which are used for medication, are intravenous set, infusion pump and needleless connectors. One of the major home infusion therapies is penn home infusion therapy that provides the various necessary treatment and medications in the comfort of patient’s own home. Some of the services that are provided by penn home infusion therapy are infectious disease, pain management, nutrition, oncology and cardiology.

Download Report Sample at: https://www.psmarketresearch.com/market-analysis/home-infusion-therapy-market/report-sample

Some of the major factors driving the growth of global home infusion therapy market are low cost of home infusion therapy compared to hospital stay costs, increasing applications of infusion devices in pain relieving, technology advancement, expanding homecare market (owing to the high costs of hospital stays and busy lifestyle), and large population of baby boomers. Whereas, issues related to reimbursement policies, increasing risk for patient’s safety and incidences of mistakes while using infusion devices are some of the factors hindering the growth of home infusion therapy market. Over dosage of medications may also cause a dangerous circumstance, which also hinders the growth of home infusion therapy market to some extent.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=home-infusion-therapy-market

North America had the largest home infusion therapy market in 2014, owing to rising number of chronic diseases and increasing healthcare costs in the region. Asia-Pacific home infusion therapy market is growing at the fastest rate, attributed mainly to the aging population of Japan and increasing expenditure on healthcare services in developing countries such as India and China.

Some of the major competitors in home infusion therapy market are Baxter International Inc., ICU Medical Inc., Terumo Corporation, JMS Co. Ltd., Becton, Dickinson and Company, Hospira, Inc., B. Braun Melsungen AG, Caesarea Medical Electronics, Smiths Group plc, and Fresenius Kabi AG.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:

P&S Intelligence

Toll-free: +1-888-778-7886 (USA/Canada)

International: +1-347-960-6455

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook